• News
  • Medical

Shire sees Lumena liver drugs sustaining growth in gut diseases

Shire Plc’s acquisition of San Diego-based Lumena Pharmaceuticals Inc. is an ideal fit for its businesses in rare genetic disorders and gut disease, and can help sustain sales growth, CEO Flemming Ornskov said.

To continue reading, subscribe now
log in to your account
User Response
0 UserComments
Subscribe Today!